NASALCROM Drug Patent Profile
✉ Email this page to a colleague
When do Nasalcrom patents expire, and when can generic versions of Nasalcrom launch?
Nasalcrom is a drug marketed by Blacksmith Brands and is included in one NDA.
The generic ingredient in NASALCROM is cromolyn sodium. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nasalcrom
A generic version of NASALCROM was approved as cromolyn sodium by SANDOZ on June 16th, 1999.
Summary for NASALCROM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 98 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,783 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | NASALCROM at DailyMed |
Recent Clinical Trials for NASALCROM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Stanley Medical Research Institute | Phase 1/Phase 2 |
| Vishwajit Nimgaonkar, MD PhD | Phase 1/Phase 2 |
| Wolfson Medical Center | Phase 3 |
US Patents and Regulatory Information for NASALCROM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blacksmith Brands | NASALCROM | cromolyn sodium | SPRAY, METERED;NASAL | 020463-001 | Jan 3, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
